CM
AMAG

Castleark Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Castleark Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-232,613
Closed -$16.1M – 414
2015
Q2 		$16.1M Sell
232,613
-45,600
-16% -$2.87M 0.43% 64
2015
Q1 		$15.2M Sell
278,213
-15,700
-5% -$748K 0.37% 87
2014
Q4 		$12.5M Buy
+293,913
New +$10.6M 0.32% 84
2013
Q4 		– Sell
-221,258
Closed -$7.06M – 409
2013
Q3 		$7.06M Buy
+221,258
New +$5.23M 0.2% 129

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Castleark Management's AMAG Position: Q3 2015 in Review

Castleark Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 232,613 shares — an estimated $16.1M sold.

Castleark Management first reported a position in AMAG in Q3 2013 and held it in 4 quarters. The position peaked at $16.1M in Q2 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

  • Castleark Management reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Castleark Management sold 232,613 AMAG Pharmaceuticals shares in Q3 2015, an estimated $16.1M.
  • Castleark Management first reported a position in AMAG Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Castleark Management's AMAG Pharmaceuticals position peaked at $16.1M in Q2 2015.
  • 210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.